,50,51 Although we were not able to investigate direct recognition of autologous cancer cells, the ability of UCPVax to trigger cytolytic CD4+ T cells suggests that they can contribute to cancer cell killing in the TME, as previously reported.52 This evidence concerns the gene CD4 and cancer.